parallel randomized trial
S003012
Type 2 diabetes (adults)S003012
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | semaglutide Test product (Intas semaglutide) | metformin; lifestyle: standard | 112 | 108 | |
| A2 | semaglutide Reference product (Novo Nordisk semaglutide) | metformin; lifestyle: standard | 111 | 109 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Test product (Intas semaglutide) A1 | Reference product (Novo Nordisk semaglutide) A2 |
|---|---|---|---|
| age | mean (years) | 49 | 48 |
| age | sd (years) | 10.2 | 10.4 |
| bmi | mean (kg/m2) | 30.8 | 30.5 |
| bmi | sd (kg/m2) | 5.6 | 5.1 |
| diabetes duration | mean (months) | 44 | 42 |
| female | n | 46 | 58 |
| female | percent | 42.6 | 53.2 |
| hba1c | mean (percent) | 8.4 | 8.4 |
| hba1c | sd (percent) | 1.0 | 0.9 |
| weight | mean (kg) | 80.7 | 79.1 |
| weight | sd (kg) | 15.7 | 16.7 |
Results
37 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (8 lines; O01)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | change | -1.50 percent | 108 | not stated; modified itt; R0014460:Table 2 | ||
| 24 | A1 | change | -1.51 percent | 108 | not stated; modified itt; R0014460:Table 2 | ||
| 24 | A1 | change | -1.54 percent | 105 | not stated; per protocol; R0014460:Supplement Table 1 | ||
| 24 | A1 vs A2 | md | 0.16 percent | -0.16 to 0.47 | not stated; modified itt; R0014460:Table 2 | ||
| 24 | A1 vs A2 | md | 0.15 percent | -0.16 to 0.46 | not stated; per protocol; R0014460:Supplement Table 1 | ||
| 24 | A2 | change | -1.65 percent | 109 | not stated; modified itt; R0014460:Table 2 | ||
| 24 | A2 | change | -1.63 percent | 109 | not stated; modified itt; R0014460:Table 2 | ||
| 24 | A2 | change | -1.69 percent | 100 | not stated; per protocol; R0014460:Supplement Table 1 |
Body weight change in kilograms (diabetes) (2 lines; O02)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | change | -6.0 kg | 3.3 | not stated; modified itt; R0014460:Results | ||
| 24 | A2 | change | -5.8 kg | 3.7 | not stated; modified itt; R0014460:Results |
Level 2 or 3 hypoglycemia (participants) (2 lines; O04)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 6 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 7 / 111 | not stated; safety; R0014460:Table 3 |
Weight loss of 5 percent or more (2 lines; O11A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | responders | 69.4 | 108 | not stated; modified itt; R0014460:Results | ||
| 24 | A2 | responders | 66.1 | 109 | not stated; modified itt; R0014460:Results |
Weight loss of 10 percent or more (2 lines; O11B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | responders | 19.4 | 108 | not stated; modified itt; R0014460:Results | ||
| 24 | A2 | responders | 15.6 | 109 | not stated; modified itt; R0014460:Results |
Acute kidney injury (1 lines; O121)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
All cause mortality (2 lines; O20)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
Hospitalization for heart failure (2 lines; O23)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
Serious adverse events (2 lines; O25)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
Discontinuation due to adverse events (2 lines; O26)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
Nausea (2 lines; O27A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 8 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 9 / 111 | not stated; safety; R0014460:Table 3 |
Vomiting (2 lines; O27B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 7 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 10 / 111 | not stated; safety; R0014460:Table 3 |
Diarrhea (2 lines; O27C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 7 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 10 / 111 | not stated; safety; R0014460:Table 3 |
Constipation (2 lines; O27D)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 7 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
Discontinuation due to gastrointestinal adverse events (2 lines; O27E)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |
Death by suicide (2 lines; O35B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 112 | not stated; safety; R0014460:Table 3 | ||||
| A2 | events | 0 / 111 | not stated; safety; R0014460:Table 3 |